|
|
|
|
|
|
Kristin came to Health Advances in 2002 with extensive experience as a research
scientist in the diagnostics and drug discovery industries. Prior to joining
Health Advances, Kristin focused on genetic test and technology development
at Genzyme and in genomics research at Oscient Pharmaceuticals (formerly Genome Therapeutics).
At Health Advances, Kristin has combined her consulting and scientific experience to
provide results-oriented projects for her clients in the biotech and clinical diagnostics
sectors, including focus on launch strategy, pricing, and R&D prioritization for prenatal,
infectious disease, oncology and cardiovascular disease diagnostics and biotech tools.
Kristin's clients range from small diagnostics and tools start-ups to the largest public
companies in the industry.
Kristin received her Bachelors degree in Biochemistry from Smith College and her Masters
degree in Epidemiology, Health Management, and Maternal and Child Health from the Harvard
School of Public Health.
|
|
 |
|
|
|
|
